the prescription is filled by a retail or licensed compounding pharmacy
But, federal law currently prohibits Medicare from covering medications used solely for weight loss , which means Zepbound is nt covered when prescribed specifically for weight management
Retatrutide (LY3437943) is a synthetic triple agonist of GLP-1, GIP, and glucagon receptors developed by Eli Lilly, enabling simultaneous modulation of appetite, glycemic control, energy expenditure, and lipid metabolism
Most first-cycle side effects (palpitations, nausea) have resolved by end of week 2
Peptide therapies are often explored as part of a comprehensive health strategy that may also include nutrition guidance, activity recommendations, and ongoing medical support
It is a prescription medication that is given by injection